Results 1 to 10 of about 25,627 (119)

Progressive motor weakness in transgenic mice expressing human TDP-43

open access: yesNeurobiology of Disease, 2010
Familial ALS patients with TDP-43 gene mutations and sporadic ALS patients share common TDP-43 neuronal pathology. To delineate mechanisms underlying TDP-43 proteinopathies, transgenic mice expressing A315T, M337V or wild type human TDP-43 were generated.
Nancy R Stallings   +2 more
exaly   +3 more sources

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy

open access: yesIbrain, 2021
TDP‐43 proteinopathy is a kind of neurodegenerative diseases related to the TAR DNA‐binding protein of 43‐kDa molecular weight (TDP‐43). The typical neurodegenerative diseases include amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration
Zi‐Qi Huang   +4 more
doaj   +1 more source

Integration of FUNDC1-associated mitochondrial protein import and mitochondrial quality control contributes to TDP-43 degradation

open access: yesCell Death and Disease, 2023
Though TDP-43 protein can be translocated into mitochondria and causes mitochondrial damage in TDP-43 proteinopathy, little is known about how TDP-43 is imported into mitochondria.
Jinfa Ma   +7 more
doaj   +1 more source

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

open access: yesActa Neuropathologica Communications, 2022
Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is a neurodegenerative disease primarily affecting the frontal and/or temporal cortices.
Sarah Pickles   +18 more
doaj   +1 more source

TDP-43 Oligomerization and Phase Separation Properties Are Necessary for Autoregulation

open access: yesFrontiers in Neuroscience, 2022
Loss of TDP-43 protein homeostasis and dysfunction, in particular TDP-43 aggregation, are tied to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Lydia C. Koehler   +5 more
doaj   +1 more source

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy

open access: yeseLife, 2023
TDP-43 proteinopathies including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative disorders characterized by aggregation and mislocalization of the nucleic acid-binding protein TDP-43 and subsequent ...
Julie C Necarsulmer   +16 more
doaj   +1 more source

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy

open access: yesFrontiers in Aging Neuroscience, 2020
Through a number of an extensive autopsy, biomarker, and genomics studies, researchers have recently defined a novel type of dementia known as limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE is perhaps best characterized by the presence
Lumi Zhang   +6 more
doaj   +1 more source

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice

open access: yesMolecular Therapy: Nucleic Acids, 2023
The abnormal aggregation of TDP-43 into cytoplasmic inclusions in affected neurons is a pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Toshihide Takeuchi   +15 more
doaj   +1 more source

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera

open access: yesJournal of Biomedical Science, 2023
Background Amyotrophic lateral sclerosis (ALS) associated with TAR DNA-binding protein 43 (TDP-43) aggregation has been considered as a lethal and progressive motor neuron disease.
Yu-Ling Tseng   +8 more
doaj   +1 more source

TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains

open access: yesMolecular Neurodegeneration, 2023
Background Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD).
Virginia Estades Ayuso   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy